Inclisiran

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available. Jan 14, 2024